Your browser doesn't support javascript.
loading
Prioritising access to cancer drugs.
Puyat, Corinna Victoria M; Eala, Michelle Ann B; Dee, Edward Christopher; Tantengco, Ourlad Alzeus G; Cruz, Anna Rominia D P; Faylona, Edgar A; Germar, Maria Julieta V; Sacdalan, Dennis L.
Afiliación
  • Puyat CVM; College of Medicine, University of the Philippines, Manila, Philippines.
  • Eala MAB; College of Medicine, University of the Philippines, Manila, Philippines.
  • Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tantengco OAG; College of Medicine, University of the Philippines, Manila, Philippines.
  • Cruz ARDP; College of Medicine, University of the Philippines, Manila, Philippines.
  • Faylona EA; Cancer and Blood Specialists of Nevada, Las Vegas, NV, USA.
  • Germar MJV; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Philippine General Hospital, Manila, Philippines.
  • Sacdalan DL; Division of Medical Oncology, Department of Internal Medicine, Philippine General Hospital, Manila 1000, Philippines. Electronic address: dlsacdalan1@up.edu.ph.
Lancet Oncol ; 23(1): e2, 2022 01.
Article en En | MEDLINE | ID: mdl-34973227
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Filipinas
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Filipinas